Table 2.
Studies evaluating the use of IPCs in hepatic hydrothorax
| Study | Study design | Sample size (n) | Pleurodesis success (%) | Mean time to pleurodesis (days) | Pleural infection rate (%) |
|---|---|---|---|---|---|
| Bhatnagar et al. (2014) [5] | Prospective, multicentre | 19 | 10 | 222 | 5.3 |
| Chen et al. (2016) [24] | Prospective, single centre | 24 | 33 | 131.8 | 16.7 |
| Kinese et al. (2019) [25] | Retrospective, single centre | 62 | 14.5 | 118 | 16 |
| Shojaee et al. (2019) [26] | Retrospective, single centre | 79 | 27.8 | 55 | 10 |
| Bartnicki-Navarette et al. (2020) [27] | Retrospective | 13 | 69 | 34 | 7.6 |
| Walker et al. (2022) [20] | Multicentre RCT | 8 | NR | NR | 0 |
NR not recorded, IPC indwelling pleural catheters